baber/WOPTO huggingface dataset:
Patent AU-702438-B2 (AU)
Title: DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
Inventor: BARD JONATHAN A
IPC: C12N5/10
Filed: 1994-12-28
Granted: 1999-02-18
Abstract: This invention provides an isolated nucleic acid molecule encoding a human Y4 receptor, an isolated protein which is a human Y4 receptor, vectors comprising an isolated nucleic acid molecule encoding a human Y4 receptor, mammalian cells comprising such vectors, antibodies directed to the human Y4 receptor, nucleic acid probes useful for detecting nucleic acid encoding human Y4 receptor, antisense oligonucleotides complementary to any sequences of a nucleic acid molecule which encodes a human Y4 receptor, pharmaceutical compounds related to human Y4 receptors, and nonhuman transgenic animals which express DNA encoding a normal or a mutant human Y4 receptor. This invention further provides methods for determining ligand binding, detecting expression, drug screening, and treatment involving the human Y4 receptor.
Patent AU-686327-B2 (AU)
Title: Cosmetic compositions
Inventor: FANKHAUSER PETER
IPC: A61K8/36
Filed: 1995-02-06
Granted: 1998-02-05
Abstract: PCT No. PCT/EP95/00408 Sec. 371 Date Aug. 12, 1996 Sec. 102(e) Date Aug. 12, 1996 PCT Filed Feb. 6, 1995 PCT Pub. No. WO95/22310 PCT Pub. Date Aug. 24, 1995A cosmetic composition is provided comprising: A) a cosmetically acceptable carrier; and B) 0.05 to 3.0% by weight, based on the weight of the total composition, of a  beta -1,3-glucan having a mean molecular weight of 105 to 25.106.
Patent AU-730842-B2 (AU)
Title: Humanized green fluorescent protein genes and methods
Inventor: ZOLOTUKHIN SERGEI
IPC: C12N15/00
Filed: 1997-01-17
Granted: 2001-03-15
Abstract: Disclosed are synthetic and "humanized" versions of green fluorescent protein (GFP) genes adapted for high level expression in mammalian cells, especially those of human origin. Base substitutions are made in various codons in order to change the codon usage to one more appropriate for expression in mammalian cells. Recombinant vectors carrying such humanized genes are also disclosed. In addition, various methods for using the efficient expression of humanized GFP in mammalian cells and in animals are described.
Patent AU-648905-B2 (AU)
Title: A solenoid device
Inventor: MIYAZAWA SHOZO
IPC: F16K31/06
Filed: 1992-06-29
Granted: 1994-05-05
Abstract: This invention relates to a solenoid device for a flow rate control valve and a displacement sensor. In a conventional solenoid device, it is not possible to obtain the characteristics permitting ease-of-control of the voltage applied to an electromagnetic coil and the stroke of a plunger, or the stroke of the plunger and the oscillation frequency of the coil. Thus, it is difficult to carry out a control operation or accurate measurement, and the stroke of the plunger is short. Therefore, in the present invention, the above problems are solved by forming an end portion of the plunger convergently, whereby the present invention can provide a solenoid device having linear characteristics and used suitably for a long-stroke electromagnetic valve or a highly accurate displacement sensor.
Patent AU-712241-B2 (AU)
Title: Immunosuppressive compounds and methods
Inventor: MUSSER JOHN H
IPC: C07D307/77
Filed: 1997-02-28
Granted: 1999-11-04
Abstract: Compounds and methods for use in immunosuppressive and anti-inflammatory treatment are described. The compounds are triptolide analogs with improved water solubility and low toxicity.
Patent AU-701991-B2 (AU)
Title: Process and device for lacquering or coating a substrate
Inventor: APPICH KARL
IPC: B05C11/105
Filed: 1995-03-11
Granted: 1999-02-11
Abstract: The appts. includes a container (10) from which a substrate (29) is covered with liq. (11) through a capillary tube (13) ending in a nozzle (40). A coating (31) is typically formed up to 5 to 50 microns thick in the wet condition. The structure (12) enclosing the capillary is mounted on a vertical rod (15) movable within a bellows (17) by e.g. a hydraulic or pneumatic jack (44). Upon completion of a coating, the tube is lowered through the aperture (48) in the top of the container, until the nozzle is below the surface of the liquid. The aperture is closed (46) by translation of a cover plate (19).
Patent AU-754329-B2 (AU)
Title: Fungicide composition comprising a benzoylphenylurea
Inventor: BEN-ZIONY YAIR
IPC: C07C275/54
Filed: 1999-01-26
Granted: 2002-11-14
Abstract: The present invention provides a pharmaceutical or veterinary composition comprising, a carrier and an active ingredient being a compound of the following formula I: wherein R1 and R2 are each independently hydrogen, halogen or methoxy, as well as salts of the compound of formula I. Further provided by the invention is a method of treatment of fungal infection, comprising administering to a patient in need, an effective amount of the compound of said formula I.
Patent AU-659479-B2 (AU)
Title: Use of acid sodium polyphosphates in the manufacture of cheese
Inventor: MERKENICH KARL DR
IPC: A23C19/082
Filed: 1992-07-08
Granted: 1995-05-18
Abstract: PCT No. PCT/EP92/01533 Sec. 371 Date Aug. 15, 1994 Sec. 102(e) Date Aug. 15, 1994 PCT Filed Jul. 8, 1992 PCT Pub. No. WO93/03623 PCT Pub. Date Mar. 4, 1993.The invention concerns the use of acidic sodium polyphosphates and Maddrell's salt for the production of natural cheese, processed cheese and cheese preparations which have a P2O5 content of 73-77 wt. %, on Na2O content of 20-25 wt. %, a water content of 2-3 wt. % and an average linear degree of condensation of 8-20. Preferred are the polyphosphates which are present as comparatively long chains (catena compounds) which are possible cross-linked and contain sodium metaphospbates (tri- and tetra-phosphates) in below 2 wt. %.
Patent AU-578011-B2 (AU)
Title: A polycistronic expression vector for vertebrate cells
Inventor: LEVINSON ARTHUR DAVID
IPC: C12P21/02
Filed: 1984-01-17
Granted: 1988-10-13
Abstract: An expression vector capable of expressing in a vertebrate host cell culture a desired protein and a secondary protein, which vector comprises a DNA sequence encoding for a desired protein and a DNA sequence encoding for a secondary protein wherein both said DNA sequences are operably linked to the same promoter sequence and separated by translational stop and start codons. 
<??>The secondary sequence provides for a convenient screening marker, both for transformants in general, and for transformants showing high expression levels for the primary sequence, as well as serving as a control device whereby the expression of a desired polypeptide can be regulated, most frequently enhanced.
Patent AU-776577-B2 (AU)
Title: Full body atomised bath and method for providing a full body atomised bath
Inventor: BUSSELMANN MANFRED
IPC: A61H33/10
Filed: 1999-12-16
Granted: 2004-09-16
Abstract: A method for administering a full-body mist bath, as well as a full-body mist-bath unit, having a bathing cubicle for accommodating at least one person and atomized liquid. A liquid atomizer is provided with a high-pressure chamber in which the liquid is compressed by the action of a high pressure to prepare the atomized liquid. A nozzle is provided for explosive ejection of the compressed liquid subjected to high pressure, so that it bursts apart into small particles. In the process, the particles become positively charged and their photon emission is increased.
Patent AU-669856-B2 (AU)
Title: Compositions and methods for the sublingual or buccal administration of therapeutic agents
Inventor: LU MOU-YING FU
IPC: A61K47/44
Filed: 1992-08-18
Granted: 1996-06-27
Abstract: Pharmaceutical compositions for the sublingual or buccal administration of therapeutic agents (particularly polypeptides) which are normally degraded upon oral administration comprise such a therapeutic agent, a solvent, optionally a cosolvent and/or hydrogel, and an oral mucosal membrane transport enhancing agent which is selected from the group consisting of essential and volatile oils and inorganic and organic acids.
Patent AU-714024-B2 (AU)
Title: Tetrahydrobetacarboline compounds
Inventor: AUDIA JAMES E
IPC: C07D471/04
Filed: 1997-03-24
Granted: 1999-12-16
Abstract: The present invention provides novel tetrahydro-beta-carboline compounds having useful central nervous system activity. The invention provides formulations and methods for using the novel tetrahydro-beta-carboline and related compounds. Such compounds are particularly useful for the modulation of a 5-HT2B receptor.
Patent AU-565722-B2 (AU)
Title: Mixing apparatus for treating materials capable of flow
Inventor: EIRICH WILLI
IPC: B28C5/32
Filed: 1984-04-04
Granted: 1987-09-24
Abstract: PCT No. PCT/DE84/00085 Sec. 371 Date Sep. 19, 1984 Sec. 102(e) Date Sep. 19, 1984 PCT Filed Apr. 9, 1984 PCT Pub. No. WO84/04055 PCT Pub. Date Oct. 25, 1984.Described is an apparatus for treating materials which are capable of flow, comprising a container (1) which rotates about is central axis (5) which is inclined with respect to the vertical, with a wall and/or bottom scraper plate (2) which is arranged substantially stationarily with respect to the cylindrical inside wall of the container (1), a discharge opening (3) disposed in the bottom of the container (1) and a rotating tool (6) which engages into the material. To reduce the amount of power consumed, while giving good treatment effects, and to enhance the output of the machine, with respect to the available volume in the machine, it is proposed according to the invention, that the container (1) is driven at a sub-critical speed of rotation, the rotating tool (6) is arranged exclusively at the downstream side of the apex, that the space on the upstream side is free of fittings therein and that the scraper plate (2) is disposed in the vicinity of the apex of the container (1).
Patent AU-623617-B2 (AU)
Title: Actuating device in a toy track assembly
Inventor: BOLLI PETER
IPC: A63H19/32
Filed: 1988-12-15
Granted: 1992-05-21
Abstract: The points (61) for a cogwheel railway, which has smooth tracks with a centrally arranged rack, has an adjusting device (64) with one curved (62) and one straight (63) rack piece for the respective travelling direction. The adjusting device (64), bearing these rack pieces (62, 63), is adjustable laterally relative to the track direction. Each end portion (66, 67) of the points (61) to be trailed is provided with a tongue-shaped actuating element (33) which is arranged longitudinally displaceably in a longitudinal slot (31) of the fixed rack of the relevant end portion (66, 67) and has an upwardly projecting catch (35). The catch (35) projects over the rack in the outer position of the actuating element (33) and, in its inner position, is lowered to the level of the rack. Each actuating element (33) is coupled via attached levers (41, 42) with a rotatably mounted disc (43) which, in turn, is coupled with the adjusting device (64). A vehicle, trailing the points (61), actuates the catch (35) in the case of the latter projecting. The points (61) are thus correctly switched and, at the same time, the catch (35) of the other actuating element (33) is advanced. Unproblematic trailing of the points (61) is thereby guaranteed automatically and mechanically independently of its position. 
<IMAGE>
Patent AU-701528-B2 (AU)
Title: Novel therapeutic and dietetic uses of a brain phospholipid-based complex
Inventor: PONROY YVES
IPC: A61K35/30
Filed: 1995-06-13
Granted: 1999-01-28
Abstract: PCT No. PCT/FR95/00771 Sec. 371 Date Feb. 27, 1996 Sec. 102(e) Date Feb. 27, 1996 PCT Filed Jun. 13, 1995 PCT Pub. No. WO96/00077 PCT Pub. Date Jan. 4, 1996The therapeutic or dietetic use of a preparation based on phospholipids extracted from pig brains for treating aging disorders consisting of memory disorders, attention disorders, intellectual efficacy disorders, humor and affectivity disorders, and thinking difficulty in a human is disclosed. The purified brain phospholipids are used alone or in combination with carriers and diluents enabling oral delivery.
Patent AU-766660-B2 (AU)
Title: Utilization of material containing docosapentaenoic acid
Inventor: IGARASHI OSAMU
IPC: A23L33/12
Filed: 2000-03-06
Granted: 2003-10-23
Abstract: A novel technique for relieving arachidonic acid deficient conditions and maintaining a good fatty acid balance in vivo. Utilizaiton of a DPA-containing material for relieving arachidonic acid deficient conditions and maintaining a good fatty acid balance in vivo; and compositions for relieving arachidonic acid deficient conditions and maintaining a good fatty acid balance in vivo which contain a DPA-containing material in an amount efficacious in relieving arachidonic acid deficient conditions and maintaining a good fatty acid balance in vivo per unit dose.
Patent AU-569298-B2 (AU)
Title: 1, 4-dihydro pyridine derivatives
Inventor: STOLTEFUSS JURGEN
IPC: C07D401/12
Filed: 1984-05-25
Granted: 1988-01-28
Abstract: A 1,4-dihydropyridine derivative of the formula   <IMAGE>   in which R and R1 each independently is hydrogen, C1-C4-alkyl, C1 to C12-alkoxy, C1-C4-halogenoalkoxy, halogen, nitro, trifluoromethyl, <IMAGE>   <IMAGE>  X is oxygen or sulphur, R4 and R5 each independently is hydrogen, C1-C4-alkyl, C1-C6-alkoxy, halogen, trifluoromethyl, amino or nitro, and R2 and R3 each independently is hydrogen, a C1-C10-alkyl, C2-C10-alkenyl or C3-C10-alkinyl radical which is optionally substituted by halogen, hydroxyl, C1-C4-alkoxy, amino, mono- and di-C1-C4-alkylamino, carbo-C1-C6-alkoxy and/or nitro, a C3 to C6-membered cycloalkyl radical, a phenyl radical which is optionally substituted by C1-C4-alkyl, C1-C6-alkoxy, halogen, amino and/or nitro, or a phenyl-C1-C3-alkyl radical, or a carbohydrate radical which is optionally bonded via a C1-C8-alkyl chain to the amide nitrogen atom or a pharmaceutically acceptable acid addition salt thereof, which improves the contractility of the heart, raises the blood pressure, lowers the blood sugar, reduces the swelling of mucous membranes and affects the salt and fluid balances of a patient.
Patent AU-684199-B2 (AU)
Title: An agricultural machine
Inventor: BEIJE MARINUS
IPC: A01D78/10
Filed: 1995-09-14
Granted: 1997-12-04
Abstract: An agricultural machine having an elongate frame (2) which comprises a central frame portion (10) and, on both sides thereof, lateral frame portions (13, 14) which are pivotal about pivot shafts (12) positioned transversely to the longitudinal direction and are interconnected by a hydraulic adjusting cylinder (16) which, by means of its ends, acts in a point of application formed by a pivot shaft (22) on the lateral frame portions (13, 14), whilst the points of application of the adjusting cylinder (16) are arranged, in the outwardly folded state of the machine, at different height levels with respect to the imaginary line through the pivot shafts (12) in the frame (10), the arrangement being such that on operating the adjusting cylinder (16) always one lateral frame portion (13, 14) is pivoted to an upward position prior to the other one. <IMAGE>
Patent AU-777042-B2 (AU)
Title: Method of manufacturing a multi-layer packaging laminate and packaging laminate obtained by the method
Inventor: BERLIN MIKAEL
IPC: B05D1/34
Filed: 2001-01-25
Granted: 2004-09-30
Abstract: A multi-layer packaging laminate is produced by simultaneously applying at least two wet coating layers to a substrate web (10) in a slide coater or curtain coater having a slide block (14) over which laminar flow streams of coating liquid flow to reach the substrate web. At least one layer is less than 20 mum thick (wet) and at least one layer has oxygen barrier or scavenger properties.
Patent AU-691322-B2 (AU)
Title: Wound healing agent
Inventor: GOUDA IBRAHIM
IPC: A61L15/28
Filed: 1995-07-18
Granted: 1998-05-14
Abstract: PCT No. PCT/SE95/00875 Sec. 371 Date Dec. 31, 1996 Sec. 102(e) Date Dec. 31, 1996 PCT Filed Jul. 18, 1995 PCT Pub. No. WO96/02260 PCT Pub. Date Feb. 1, 1996The invention relates to a method for promoting the healing of dermal wounds by applying a composition containing chitosan and the polysaccharide, heparin or heparan sulfate. Heparin or heparan sulfate can be immobilized to chitosan by ionic or covalent bonds, and the degree of N-acetylation of chitosan can range from 25% to 90%. The composition can include a cellulose derivative as an additional polysaccharide to increase the viscosity of the composition. The combination of chitosan and polysaccharide, when applied to a wound site, effectively stimulates and accelerates wound healing.
Patent AU-660062-B2 (AU)
Title: An optical signal decoding arrangement
Inventor: WEDDING BERTHOLD
IPC: H04B10/2513
Filed: 1993-01-27
Granted: 1995-06-08
Abstract: In the transmission of digital signals via optical fibres (3) which have a considerable chromatic dispersion at the wavelength used, the length of the transmission link is very limited if the digital signal to be transmitted is converted into an optical signal by means of intensity modulation. If a frequency modulation (also called FSK = frequency shift keying) is used instead of the intensity modulation, the length of the link which can be bridged can be greatly increased but a suitable optical receiver is needed at the receiving end. According to the invention, a simple optical receiver (4) is used which is not sensitive to frequency modulation but to intensity modulation. This is possible because, due to the chromatic dispersion of the optical fibre (3) and resultant differences in transit time of signal components of different wavelengths ( lambda 0,  lambda 1), the initial frequency modulation becomes an intensity variation in the course of the transmission via the optical fibre (3), the course of which variation contains the digital signal to be transmitted. <IMAGE>
Patent AU-717583-B2 (AU)
Title: Method for determining blood pressure of an artery
Inventor: POLIAC MARIUS O
IPC: A61B5/021
Filed: 1997-05-28
Granted: 2000-03-30
Abstract: A method for determining blood pressure of an artery includes the steps of applying a pressure to the artery, sensing pressure data produced by the artery and deriving parameters for the sensed pressure data. The parameters are utilized for generating a first blood pressure value estimate using a first function of the parameters based upon a first range of pressure values and by generating at least one second blood pressure estimate using at least one second parameter function based upon a second blood pressure estimate using at least one second parameter function based upon a second pressure range different from the first pressure range. A blood pressure value is determined based upon the first blood pressure estimate and said at least one second blood pressure estimate.
Patent AU-656841-B2 (AU)
Title: Improved pulsatile once-a-day delivery systems for minocycline
Inventor: SHETH NITIN VADILAL
IPC: A61K9/54
Filed: 1993-02-26
Granted: 1995-02-16
Abstract: Pharmaceutical delivery systems containing 7-dimethyl 6-deoxy 6-demethyltetracycline or a non-toxic acid addition salt thereof comprising mixtures of a minor proportion of slow-release blended polymer coated spherical granules adapted to release part of the minocycline in a medium having a pH of below 3.9 and the rest in the range of from about 4.0 to about 7.5 and a major proportion of coated or uncoated quick-release granules adapted to release minocycline in a medium having a pH of less than about 3.9 and oral dosage unit form capsules containing the above are provided. These systems and formulations provide enhanced therapeutic blood levels of minocycline for at least about 24 hours when administered to a subject only once-a-day, regardless of whether the patient is fed or fasted. Methods for the preparation of the systems and formulations are provided as well.
Patent AU-616528-B2 (AU)
Title: Thickening system
Inventor: RENNIE GEORGE KERR
IPC: C09K23/56
Filed: 1989-06-06
Granted: 1991-10-31
Abstract: A liquid system includes a liquid medium and a thickening mixture, the thickening mixture being dispersed in the liquid medium and comprising a synergistic mixture of a gum-type polymer and an acrylic-type polymer. The thickening system is applicable to a wide variety of systems, including detergent and cleaning compositions.
Patent AU-628831-B2 (AU)
Title: Casting device, method for using the device, casting device of vehicle wheel, method for using the device, and vehicle wheel
Inventor: KATO TAKASHI
IPC: B22C9/28
Filed: 1989-07-31
Granted: 1992-09-24
Abstract: A method for casting a vehicle wheel using a casting device is disclosed, in which the has a mold provided with a main body (M), a casting space (4) and a gate (43). The main body (M) of the mold includes a casting space section (453) for forming the rim of the wheel, and the gate (43) is arranged at one side of said casting space section (453) and opens into said casting space section. During casting and cooling the wheel, the disk portion of the wheel is partially and separately forcefully cooled. A vehicle wheel casted with this method has miniaturized structure. As only the hub portion is forcefully cooled, the necessary tensile strength of the bolt hole in the hub portion can easily be obtained at low cost. <IMAGE>
Patent AU-702269-B2 (AU)
Title: Apparatus for providing access to field devices in a distributed control system
Inventor: TAPPERSON GARY
IPC: G05B15/02
Filed: 1995-10-20
Granted: 1999-02-18
Abstract: An apparatus for accessing field devices in a distributed control system provides non-redundant secondary access to a plurality of field devices that are controlled by a control room. An apparatus also provides redundant wireless to access field devices in a distributed control system having primary access to the field devices provided by hard-wired media that couples the field devices to the control room. The field devices are coupled to a Fieldbus control network. In a first embodiment, each field device is provided with a wireless Fieldbus port that is accessible by a wireless handheld unit or wireless terminal. In a second embodiment, each Fieldbus control network is provided with a field module having a wireless Fieldbus port that allows all devices connected to the Fieldbus control network to be accessed by a wireless handheld unit or a wireless terminal. In a third embodiment, an H2-to-H1 Fieldbus bridge (which may service a plurality of H1 control networks) is provided with a wireless Fieldbus port that allows all Fieldbus devices connected to H1 control networks serviced by the H2-to-H1 bridge to be access by a wireless handheld unit of a wireless terminal. In a fourth embodiment, a bridge/converter provides an interface between older analog control room components and newer Fieldbus field devices.
Patent AU-775560-B2 (AU)
Title: Anti-HIV 1 vaccine comprising the entire or part of the TAT HIV-1 protein
Inventor: LORET ERWANN
IPC: A61K6/00
Filed: 2000-04-12
Granted: 2004-08-05
Abstract: The invention relates to an anti HIV 1 vaccine comprising the entire or part of the Tat HIV 1 protein, in addition to the identification of said protein in individuals affected by HIV. The Tat protein is a protein of the HIV 1 Oyi variant.
Patent AU-665430-B2 (AU)
Title: 17-spiromethylene steroids
Inventor: HAMERSMA JOHANNES ANTONIUS MAR
IPC: C07J71/00
Filed: 1993-07-16
Granted: 1996-01-04
Abstract: The invention relates to a steroid derivative which steroidal skeleton is bound at carbon atom 17 to a spiromethylene ring of the formula: <CHEM> wherein Ra and Rb are independently selected from the group consisting of hydrogen, methyl, and halogen; m is 1 or 2; and the asterisk denotes carbon atom 2 of the spiromethylene ring which is carbon atom 17 (or carbon atom 17 alpha  of a homosteroid skeleton) of the steroid. The steroids have progestational or antiprogestational activity.